169 related articles for article (PubMed ID: 18507075)
1. The clinical meaning of mucin phenotype and Epstein-Barr virus infection in gastric cancer.
Nakamura Y; Yanai H; Kitoh T; Matsubara Y; Hirano A; Okamoto T; Yoshida T; Nishikawa J; Okita K
Hepatogastroenterology; 2008; 55(81):41-5. PubMed ID: 18507075
[TBL] [Abstract][Full Text] [Related]
2. Mucin and differentiation in Epstein-Barr virus-associated gastric carcinoma.
Nakamura Y; Yanai H; Kitou T; Matsubara Y; Hirano A; Okamoto T; Yoshida T; Okita K; Matsusaki K
Hepatogastroenterology; 2005; 52(64):1066-70. PubMed ID: 16001631
[TBL] [Abstract][Full Text] [Related]
3. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.
Shiroshita H; Watanabe H; Ajioka Y; Watanabe G; Nishikura K; Kitano S
Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-associated gastric carcinoma in southern India: A comparison with a large-scale Japanese series.
Kattoor J; Koriyama C; Akiba S; Itoh T; Ding S; Eizuru Y; Abraham EK; Chandralekha B; Amma NS; Nair MK
J Med Virol; 2002 Nov; 68(3):384-9. PubMed ID: 12226826
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction.
Nishikawa J; Yanai H; Hirano A; Okamoto T; Nakamura H; Matsusaki K; Kawano T; Miura O; Okita K
Scand J Gastroenterol; 2002 Jul; 37(7):825-9. PubMed ID: 12190097
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of gastric and intestinal mucin phenotypes of gastric carcinoma.
Mabuchi N; Niwa Y; Hirooka Y; Ohmiya N; Itoh A; Maeda O; Ando T; Goto H
Hepatogastroenterology; 2008; 55(88):2277-81. PubMed ID: 19260522
[TBL] [Abstract][Full Text] [Related]
7. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers.
Etoh T; Kanai Y; Ushijima S; Nakagawa T; Nakanishi Y; Sasako M; Kitano S; Hirohashi S
Am J Pathol; 2004 Feb; 164(2):689-99. PubMed ID: 14742272
[TBL] [Abstract][Full Text] [Related]
8. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
9. No association of primary adenocarcinomas of the small bowel with Epstein-Barr virus infection.
von Rahden BH; Langner C; Brücher BL; Stein HJ; Sarbia M
Mol Carcinog; 2006 May; 45(5):349-52. PubMed ID: 16493667
[TBL] [Abstract][Full Text] [Related]
10. Unclassified mucin phenotype of gastric adenocarcinoma exhibits the highest invasiveness.
Han HS; Lee SY; Lee KY; Hong SN; Kim JH; Sung IK; Park HS; Jin CJ; Min YI
J Gastroenterol Hepatol; 2009 Apr; 24(4):658-66. PubMed ID: 19175827
[TBL] [Abstract][Full Text] [Related]
11. Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas.
Kawachi H; Takizawa T; Eishi Y; Shimizu S; Kumagai J; Funata N; Koike M
J Pathol; 2003 Apr; 199(4):436-46. PubMed ID: 12635134
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan.
Koriyama C; Akiba S; Itoh T; Kijima Y; Sueyoshi K; Corvalan A; Herrera-Goepfer R; Eizuru Y
Int J Mol Med; 2002 Nov; 10(5):635-9. PubMed ID: 12373307
[TBL] [Abstract][Full Text] [Related]
13. Down regulation of gastric and intestinal phenotypic expression in Epstein-Barr virus-associated stomach cancers.
Hirano N; Tsukamoto T; Mizoshita T; Koriyama C; Akiba S; Campos F; Carrasquilla G; Carrascal E; Cao X; Toyoda T; Ban H; Miki K; Tatematsu M
Histol Histopathol; 2007 Jun; 22(6):641-9. PubMed ID: 17357094
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis.
Chang MS; Lee HS; Kim HS; Kim SH; Choi SI; Lee BL; Kim CW; Kim YI; Yang M; Kim WH
J Pathol; 2003 Apr; 199(4):447-52. PubMed ID: 12635135
[TBL] [Abstract][Full Text] [Related]
15. Malignant potential regarding mucin phenotypes and endocrine cell differentiation in gastric adenocarcinoma.
Naritomi K; Futami K; Arima S; Iwashita A
Anticancer Res; 2003; 23(6a):4411-22. PubMed ID: 14666728
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated gastric carcinoma in Papua New Guinea.
Morewaya J; Koriyama C; Akiba S; Shan D; Itoh T; Eizuru Y
Oncol Rep; 2004 Nov; 12(5):1093-8. PubMed ID: 15492798
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival.
Grogg KL; Lohse CM; Pankratz VS; Halling KC; Smyrk TC
Mod Pathol; 2003 Jul; 16(7):641-51. PubMed ID: 12861059
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma.
Li S; Du H; Wang Z; Zhou L; Zhao X; Zeng Y
Sci China Life Sci; 2010 Apr; 53(4):524-30. PubMed ID: 20596921
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-associated gastric carcinoma in Lima, Peru.
Yoshiwara E; Koriyama C; Akiba S; Itoh T; Minakami Y; Chirinos JL; Watanabe J; Takano J; Miyagui J; Hidalgo H; Chacon P; Linares V; Eizuru Y
J Exp Clin Cancer Res; 2005 Mar; 24(1):49-54. PubMed ID: 15943031
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.
Carrascal E; Koriyama C; Akiba S; Tamayo O; Itoh T; Eizuru Y; Garcia F; Sera M; Carrasquilla G; Piazuelo MB; Florez L; Bravo JC
Oncol Rep; 2003; 10(4):1059-62. PubMed ID: 12792770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
